Overview
ETC and INJ rarely move in perfect sync. Today’s print ($6.66/$5.10) and 24h leaders (Injective) help frame which side currently carries relative strength.
Quick winners
Full comparison
| Metric | ETC | INJ |
|---|---|---|
| Price | $6.66 | $5.10 |
| Market Cap | $1.05B | $490.41M |
| FDV | — | — |
| Volume 24h | $970,062.66 | $2.58M |
| Circulating Supply | — | — |
| Total Supply | — | — |
| Max Supply | — | — |
| Rank | 64.00 | 99.00 |
| Dominance | — | — |
| Liquidity | — | — |
| Volatility | +3.64% | +5.97% |
| ATH | — | — |
| ATL | — | — |
| ROI | — | — |
Performance
| Timeframe | ETC | INJ |
|---|---|---|
| 1H | — | — |
| 24H | +1.99% | +3.59% |
| 7D | — | — |
| 30D | — | — |
| 90D | — | — |
| 1Y | — | — |
| YTD | — | — |
| ALL | — | — |
Comparative chart
Technical indicators
| Indicator | ETC | INJ |
|---|---|---|
| RSI | 49.02 | 49.29 |
| MACD histogram | — | — |
| EMA20 | — | — |
| EMA50 | — | — |
| EMA100 | — | — |
| EMA200 | — | — |
| SMA50 | — | — |
| SMA200 | — | — |
| ATR | 67.35 | 0.29 |
| ADX | 21.33 | 12.19 |
| Support | 1,827.82 | 4.91 |
| Resistance | 1,960.30 | 5.47 |
| Trend | bearish | neutral |
| Momentum | 59.00 | — |
| Signal | neutral | neutral |
Automatic technical analysis
Technically, ETC shows RSI 49.02 with trend bias bearish, while Injective sits at RSI 49.29 (neutral). Divergences between momentum and price should be confirmed on higher timeframes.
Fundamentals
| Metric | ETC | INJ |
|---|---|---|
| Consensus | — | — |
| Blockchain | — | — |
| TPS | — | — |
| Block time | — | — |
| Finality | — | — |
| Validators | — | — |
| Staking | — | — |
| TVL | — | — |
| Supply model | — | — |
| Inflation | — | — |
| Developer activity | — | 0.00 |
| Github activity | — | 118.00 |
| On-chain activity | — | — |
| Whale activity | — | — |
| Addresses | — | — |
| Gas fees | — | — |
Ecosystem
ETC
Injective
Pros and cons
Pros of ETC
- ETC typically benefits from deeper liquidity and broader market recognition inside the Top 300 set.
- ETC often anchors narratives that attract sustained media and analyst coverage.
- Composite PEPS readings for ETC can surface clearer module agreement during trend phases.
- Market-cap scale on ETC may dampen some idiosyncratic shocks versus smaller peers.
Cons of ETC
- Indicator stacks on ETC may stay stretched longer than expected in strong trends.
- Large-cap status for ETC can mean slower percentage upside versus high-beta alternatives.
Pros of Injective
- If technical momentum aligns, Injective may outperform on medium-term windows.
- Diversifying versus ETC with Injective can change portfolio factor exposure.
- PEPS tracking for Injective still includes AI score and level context for monitoring.
Cons of Injective
- Higher volatility on INJ cuts both ways and demands stricter risk limits.
- Trend failures on Injective often travel faster than on more established assets.
Which looks stronger right now?
On the latest snapshot, market-cap leadership belongs to ETC, while short-term performance leans toward Injective. That mix suggests relative strength can flip quickly, so size risk accordingly.
AI summary
For readers asking which is “better”, the honest answer is conditional. ETC and Injective solve overlapping but not identical market jobs. On-chain and developer fields, when available, add slower-moving context beneath the tape. Missing fundamentals should be treated as unknown, not as zeros. If your thesis is long-term adoption, weight fundamentals and liquidity; if tactical, weight trend/momentum — and always define invalidation.
FAQ
Which is better, ETC or Injective?
“Better” depends on horizon and risk. ETC leads on market cap today, while Injective leads the 24h move — neither is a guarantee.
Which has more upside potential, ETC or INJ?
Higher-beta assets can move more in both directions. Use performance tables and volatility, not headlines, to judge potential ranges.
Which is less risky right now?
Lower volatility and deeper liquidity usually imply milder path risk, but crypto tails remain large for both ETC and Injective.
Which has stronger developer activity?
Check the fundamentals table for developer/github fields when populated. Missing values mean the feed has no reliable reading yet.
Which looks more decentralized?
Decentralization is multi-dimensional (validators, client diversity, token distribution). This page surfaces available consensus/validator fields without over-claiming.
Which has lower fees?
Fee comparisons belong to each network’s fee market. Where gas/fee metrics exist in fundamentals, compare them; otherwise verify on explorers.
Which is better for investing?
Investing choices need personal constraints. Use this comparison as research input, then size positions with an explicit invalidation plan.
Which is better for staking?
If staking fields are present, compare yield mechanics and lockups off-platform. Staking returns are not risk-free.
Which is more used day to day?
Volume, on-chain activity and ecosystem links are practical usage proxies. Injective currently leads traded volume on this snapshot.
Which has the better recent performance?
See the performance table across 1h through 1y. The 24h leader is Injective, but longer windows can disagree.